Mmaserame Gaefele

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors

D. Zelterman, K. Politi, W. Lockwood, 2018, Journal of Immunotherapy for Cancer.

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

K. Politi, W. Lockwood, Paul D. Smith, 2020, Cancer Research.